Biostax Corp (BTAX)

[locicat1]

Like to point out to you and others to revisit the November 30, 2017 Shareholder Update Letter wherein it is stated that the company is to "Complete a Scientific White Paper on Lodonal by the end of 2017 which will highlight its development history, approvals and clinical data that can be used with the regulators in low and middle-income countries. The company believes this paper will allow it to fast track the approval processes for various indications using the regional rules for drug harmonization."

I believe the end of 2017 has occurred-where is the Scientific White Paper?? All the purported information to be included would be quite important,and hopefully compiled by knowledgeable, experienced and respected scientist(s) in the immunology field. Indeed would go a long way to develop solid credibility.